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http://dx.doi.org/10.1016/j.pedneo.2Background: There is a lack of up-to-date, systematic reviews that critically assess the role
and potential limitations of evidence-based medicine (EBM) and systematic reviews in
neonatology.
Methods: We performed a systematic literature review of all Cochrane reviews published be-
tween 1996 and 2010 by the Cochrane Neonatal Review Group (CNRG). Main outcome param-
eter: assessment of the percentage of reviews that concluded that a certain intervention
provides a benefit, the percentage of reviews that concluded that no benefit was seen, and
the percentage of studies that concluded that the current level of evidence is inconclusive.
Results: In total, 262 reviews were assessed, most of which included exclusively preterm infants
(146/262). The majority of reviews assessed pharmacological interventions (145/262); other
important fields included nutritional (46/262), and ventilatory issues (27/262). In 42/262
reviews, a clear recommendation in favor of a specific intervention was given, whereas 98/
262 reviews concluded that certain interventions should not be performed. However, the largest
proportion of reviews was inconclusive (122/262) and did not issue specific recommendations.
The proportion of inconclusive reviews increased from 30% (1996e2000), to 50% (2001e2005),
and finally to 58% for the years 2006e2010. Common reasons for inconclusive reviews were the
small number of patients (105), insufficient data (94), insufficient methodological quality (87),
and heterogeneity of studies (69).of Saarland, Medical School, Campus Homburg, Building 9, 66421 Homburg, Germany.
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Undoubtedly, evidence-based medicine (EBM) has contrib-
uted substantially to improving the quality of medicine in
general, and of neonatology in particular.1 The Cochrane
Neonatal Review Group (CNRG) is one of 50 review groups
within the Cochrane Collaboration, and it is one of the most
active.2 There are a number of examples that illustrate the
importance of systematic reviews in improving the delivery
of medical care, for example, administration of antenatal
steroids, surfactant replacement therapy, hypothermia for
hypoxic ischemic encephalopathy, and probiotics to pre-
vent necrotizing enterocolitis.
A systematic review published in 1990 demonstrated
that antenatal administration of corticosteroids substanti-
vely reduced both neonatal mortality and morbidity
without negatively impacting on maternal outcomes.3 After
recommendations were issued by a number of national so-
cieties that corticosteroids should be given to all women
with impending preterm birth, a dramatic change in prac-
tice with a more than three-fold increase in antenatal
corticosteroid exposure in very-low-birth weight infants in
the Vermont Oxford Neonatal Network was seen.4,5 Some
authors argue that if a system for cumulative research
synthesis had been in place, antenatal corticosteroids may
have been adopted as a standard of care much earlier.6,7
Moreover, and of importance, Cochrane reviews have also
contributed to identifying interventions that are ineffective
or harmful, for example, administration of antenatalthyrotrophin-releasing hormone and early postnatal
administration of dexamethasone.7,8
However, although these examples undoubtedly illus-
trate the potential importance and impact of the Cochrane
database in the field of neonatology, no formal, up-to-date
analysis of all published systematic Cochrane reviews has
been performed with regard to the number of reviews with
a definitive conclusion in favor of a certain intervention,
the number of reviews with a definitive conclusion against a
certain intervention, and the number of inconclusive
reviews.
2. Methods and Clinical Questions
We conducted a systematic literature review including all
reviews from the CNRG (http://neonatal.cochrane.org/)
from 1996 to 2010 (total number: 267). Reviews that spe-
cifically addressed maternal/parental issues were excluded
from the study (n Z 5).
The following data were retrieved from the CNRG
database: (1) origin of publication by country; (2) gesta-
tional age of included study populations; (3) number of
included randomized controlled trials (RCTs) and number of
patients; (4) time of publication; and (5) type of interven-
tion (pharmacological, non-pharmacological, etc.).
The main outcome parameters were: (1) number (per-
centage) of reviews with a definitive conclusion in favor of
a certain intervention; (2) number (percentage) of reviews
with a definitive conclusion against a certain intervention;
and (3) number (percentage) of inconclusive reviews.
We subsequently analyzed the specific reasons why
reviews were considered inconclusive as provided by the
authors. We also evaluated whether differences with re-
gard to the primary outcome parameters were seen be-
tween three different, a priori defined time episodes
(1996e2000; 2001e2005; 2006e2010). We also assessed
potential differences with regard to the primary outcome
parameters between initial publications and the latest up-
dates of review.
All data were retrieved from the CNRG and stored in an
electronic database, using SPSS 18.0 (SPSS, Chicago, IL,
USA). If necessary, the original publications were retrieved
from the Cochrane database and hand-searched for missing
data with regard to our study questions. Information was
added to the database if indicated. Data are presented as
mean, median, standard deviation, and range.
3. Results
In total, 262 reviews were included in this study; five re-
views were excluded because they dealt exclusively with
Figure 1 (A) Gestational age of neonates of included studies.
(B) Birth weight of neonates of included studies.
AGAZ adequate for age; ELBWZ extremely low birth weight;
GA Z gestational age; LBW Z low birth weight; VLBW Z very
low birth weight.
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reviews were performed in Western, industrialized coun-
tries (Australia, North America, and Europe: 247/262),
whereas only a minority of papers originated from devel-
oping countries (15/262). The USA and Canada both
contributed 44 reviews, while the United Kingdom was the
major contributing country within Europe (35/262). Most
studies were performed exclusively on preterm neonates
(146/262), and 42/262 included both preterm and term
infants. Thirteen reviews involved term neonates only; in
35 reports no specific data with regard to gestational age
were provided (more detailed information with regard to
gestational age and birth weight is given in Figure 1A
and B). In 26 Cochrane reviews, no RCTs were available for
enrolment.
The mean number of studies initially considered for a
specific review was 12.6 (median: 7; range: 0e111), while
the number of studies finally included was 5.5 (median: 3;
range: 0e64), and the number of patients included was
727.9 (median: 208; range: 0e21,070). Table 1 provides
specific information with regard to the number of included
trials and patients per review and date of publication.Table 1 Number of studies and patients (in parenthesis)
included according to time period of publications.
1996e2000 2001e2005 2006e2010
Mean 7.0 (930.9) 4.9 (697.9) 4.4 (483.7)
SEM 0.7 (139.6) 0.8 (217.2) 0.8 (90.8)
Minimum 0 (0) 0 (0) 0 (0)
Maximum 44 (546) 64 (21,070) 28 (2701)
SEM Z standard error of the mean.There was a reduction in the number of included reviews
over time (1996e2000: 95; 2001e2005: 109; 2006e2010:
58). In total, 167/262 of reviews have been updated since
their original publication, while the remaining 95 papers
have not been revised (1996e2000: 86 updated;
2001e2005: 68 updated; 2006e2010: 13 updated).
When looking at type of intervention, the majority of
reviews examined pharmacological interventions (145/
262), nutrition (46/262), and ventilation and ventilatory
support (27/262), while the remaining reviews analyzed a
variety of issues, including surgery/invasive procedures,
non-pharmacological pain therapy, physiotherapy, neuro-
developmental issues, and others (Figure 2A). With regard
to organ system, the following organs were analyzed: lung
(90/262), cardiovascular system (65/262), intestinal and
digestive system (49/262), central nervous system and eyes
(23 þ 4/262), kidney (2/262), and others (49/262)
(Figure 2B).
Of all 262 reviews, 42 reviews gave a clear recommen-
dation in favor of specific interventions (positive recom-
mendation), while 98/262 reviews concluded that certain
interventions should not be performed (negative recom-
mendation). However, the largest proportion of reviews
was inconclusive (122/262) and did not provide specific
recommendations. Seven out of those 122 reviews issuedFigure 2 (A) Types of interventions assessed by Cochrane
reviews. (B) Number of reviews/therapeutic interventions with
regard to organ system.
Figure 3 Number of conclusive and inconclusive reviews
depending on status updated or not updated.
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generalized for neonates or preterm infants. Of note, the
percentage of inconclusive reviews increased from 30%
(1996e2000) to 50% (2001e2005), and finally to 58% for the
years 2006e2010. There were 33 updated reviews with a
positive recommendation and 65 with a negative recom-
mendation, while 69 reviews were inconclusive. In non-
updated reviews, nine issued a positive recommendation,
33 a negative recommendation, and 53 were inconclusive
(Figure 3).
The three most common reasons (multiple entries
possible) for inconclusive reviews were the small number of
patients (105), insufficient data (94), and poor and insuffi-
cient methodological quality (87) (Figure 4).4. Discussion
EBM plays an ever more important role in the delivery of
medicine, including neonatology. Recent reports have
shown good agreement between Cochrane reviews and
local neonatal guidelines at the level of university hospi-
tals,9 although discrepancies between recommendations
from systematic reviews and local practice continue to
exist.
In this review, we demonstrated that the use of sys-
tematic reviews as provided by the CNRG plays anFigure 4 Main reasons for inclusive data in Cochrane
reviews.important role in disseminating the best available evi-
dence, thus contributing to the provision of good medical
care at the bedside. A substantial proportion of systematic
reviews provided data with regard to the question of
whether a certain intervention should or should not be
performed (42 positive; 98 negative). This will provide the
physician at the bedside with invaluable information with
regard to both optimal and unnecessary treatment modal-
ities. However, interpretation and possibly implementation
of these data should only be carried out in conjunction with
“local modifiers”, for example, the decision to use intra-
muscular vitamin A to prevent bronchopulmonary dysplasia
(BPD) may depend on “local” BPD incidence rates. It is also
noteworthy that the vast majority of reviews published in
the CNRG originate from Western, industrialized countries.
Thus, the recommendations issued in these reviews are
almost exclusively applicable to the field of neonatology as
practiced in industrialized countries, which excludes the
majority of neonates being born and cared for in the
developing world. However, recently, efforts (through ini-
tiatives such as the Effective Health Care Alliance and the
‘‘Sea-orchid’’ consortium) have been undertaken to
disseminate knowledge from the CNRG to low- and middle-
income countries to ensure that care practices are
evidence-based and that scarce resources are used and
allocated appropriately.7,10
However, and of note, our study also demonstrated that
a substantial percentage of systematic Cochrane reviews
were inconclusive and did not provide any recommendation
with regard to a specific intervention. This is in line with
previous reports on this subject.11,12 These reviews usually
conclude that, following an extensive literature search and
appraisal, “insufficient trial evidence was found to guide
clinical practice”.12 Often, only a trend can be seen, or
statistically significant changes can only be seen for short-
term outcome parameters (e.g., ventilated days),13 but
not for long-term outcome parameters (e.g., the incidence
of death or chronic lung disease at 36 weeks, intraven-
tricular hemorrhage grade 3 or 4 or periventricular leuco-
malacia).14 Moreover, it is noteworthy that a recent
analysis demonstrated that many apparently conclusive
Cochrane neonatal meta-analyses may become inconclu-
sive when the statistical analyses take into account the risk
of random error due to repetitive testing.15 Moreover, in
previous reports, neonatal Cochrane meta-analyses have
been criticized for a lack of an a priori plan for heteroge-
neity assessment and how to handle heterogeneity in case
it exists.16
The most common reasons for failure to generate spe-
cific recommendation in our analysis were attributed to the
small number of patients, poor and insufficient methodol-
ogy, and heterogeneous study populations. Although
defining clinical uncertainty and thereby generating new
research questions is a fundamental driving force for
evidence-based medicine, clinicians at the bedside will find
this frustrating and unhelpful.7 However, by identifying
important gaps in the evidence, Cochrane reviews have the
potential to promote high-quality RCTs in the field of
perinatology (e.g., collaborative quality improvement ini-
tiatives such as the WOMBAT collaboration in Australasia
(see: http://www.wombatcollaboration.net/)).7 This can
be illustrated by the fact that several recent large RCTs in
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reviews had highlighted important areas of clinical uncer-
tainty. Recent examples of neonatal interventions include
the “Benefits of Oxygen Saturation Targeting” (BOOST) and
“Pulse Oximetry Saturation Trial for Prevention of Reti-
nopathy of Prematurity” (POST ROP),17 and the “Caffeine
for Apnea of Prematurity” (CAP) trial.18 Moreover, clinical
researchers have conceptualized a research cycle that in-
cludes systematic review and observations of the effects in
practice.19 Of note, so far Australia has been by far the
largest contributor to the CNRG.
If the above outlined approach is bound to be successful,
one would expect an increasing number of high quality (and
likely conclusive) reviews that are based on sophisticated
research data. However, on the contrary and surprisingly,
we noted a tendency with an increase in the number of
inconclusive reviews over the 15-year study period, thus
generating more uncertainty than certainty in the field of
neonatology. This is in line with a previous study on this
subject,12 and is likely attributed to the fact that the
number of RCTs and number of patients per Cochrane re-
view decreased over the three, a priori defined study epi-
sodes (Table 1). Moreover, when specifically comparing
updated versus non-updated reviews, the number of
conclusive (either positive or negative recommendation)
reviews was substantially higher in updated reviews
(98/167 vs. 42/95), and the number of updated reviews was
substantially higher in the early periods. The decrease in
the number of updated reviews in the CNRG is in part
attributable to the time-consuming process of frequent
updating as mandated by the Cochrane protocol.7,20
We suggest that future, clinical studies in neonatology
should also assess a “compound” interventional approach,
for example, a “lung protective approach” (e.g., permis-
sive hypercapnea plus use of diuretics, plus fluid restric-
tion) versus a “conventional approach”. These studies
should combine two or more interventions that have proved
to be partially beneficial (positive trend) and assess pro-
spectively whether the combination of these interventions
will improve outcome parameters in the premature infant.
This change in paradigm will have the potential to
contribute more substantially to our knowledge in the
complex field of neonatology and impact more profoundly
on our therapeutic approach than studies that assess single
interventions alone. In line with this “new” strategy, a
recent study has demonstrated that implementation of a
number of potentially better practices [i.e., (1) exclusive
use of bubble continuous positive airway pressure (bCPAP),
(2) provision of bCPAP in the delivery room, (3) strict
intubation criteria, (4) strict extubation criteria, and (5)
prolonged CPAP to avoid supplemental oxygen] reduced the
need for mechanical ventilation, surfactant, and supple-
mental oxygen as well as reduced hypotension among in-
fants born before 33 weeks’ gestation without adverse
consequences. Moreover, in this report the costs for
equipment and surfactant were lower.21
Undoubtedly, multi-interventional protocols may have
obvious drawbacks as well: namely, it is difficult to know
what is helping or hurting when several parameters are
manipulated simultaneously. As a matter of fact it was due
to this difficulty that RCTs were designed in the first place.
Thus, we should be prudent and determine whether newstatistical methods made possible by bigger and better
computers that allow analysis of much bigger datasets will
allow meaningful results to be derived from more complex
study designs.22
5. Conclusions
In summary, this is the first systematic analysis of the po-
tential role and limitations of Cochrane reviews in the field
of neonatology. Our findings demonstrate that there is a
need for more high-quality research in the field of neona-
tology. The realization of high-quality research will in turn
result in more systematic reviews that will come to a clear
conclusion (i.e., in favor or against a certain intervention,
or treatment modality, etc.), as demonstrated in the
updated versions of Cochrane reviews. It will be of para-
mount importance that funding and research agencies will
support those research programs that address the most
relevant issues in the field of neonatology. Although our
study focused on practical issues, there is no question that
the CNRG and Cochrane reviews play an outstanding role in
providing systematic, up-to-date research data and,
importantly, in generating and prioritizing new research
questions for funding, action, and clinical collaboration,
thus informing both practice and research audiences.
Moreover, although Cochrane reviews are not a substitute
for guidelines issued by national or international medical
societies, the CNRG has acted as a driving force and pro-
moter of implementing guidelines on both international and
national levels (e.g., www.awmf.org/leitlinien/detail/ll/
024-014.html).
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